NIH-funded research NIH-funded research

Understanding how cell signals change in cancer and heart disease

Official title: Redox regulation of protein kinase function: biochemical mechanisms and cellular consequences

Funded at North Carolina Agri & Tech St Univ · NIH-11144265 · Data updated 2026-11-12

This work explores how changes in cell signals, particularly those affected by oxygen, contribute to diseases like cancer and cardiovascular conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorth Carolina Agri & Tech St Univ
NIH-funded
Lab location1 site (Greensboro, United States)
Project startAugust 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$362,500
NIH project number5R35GM153737-02
Project IDNIH-11144265 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research does not directly involve patients, but future clinical applications would target individuals with specific types of cancer or cardiovascular conditions linked to these cellular signaling pathways.

Less likely to help

Patients without conditions related to the specific cellular signaling pathways being studied would not directly benefit from this particular research.

What this research studies

Our bodies rely on complex signaling networks within cells to stay healthy, and when these networks go awry, it can lead to serious illnesses. This project focuses on how certain proteins, called protein kinases, are regulated by a process involving reactive oxygen species, which are natural chemicals in our cells. We want to understand how these oxygen-related changes affect the activity and location of these kinases, as this could be a key factor in the development of diseases. By uncovering these basic mechanisms, we hope to find new ways to target these processes for future treatments.

Why it matters

Potential benefit: If successful, this basic science could lead to a deeper understanding of disease mechanisms, potentially paving the way for new drug targets or therapies for cancer and cardiovascular diseases.

How similar studies have gone: Other studies have shown that protein kinases can be regulated by oxidation, suggesting this is a promising area for further investigation.

Where this research is happening

  • North Carolina Agri & Tech St Univ
    Greensboro, United States
    Active

Researchers

  • Principal investigator: Newman, Robert Howard — North Carolina Agri & Tech St Univ
  • Study coordinator: Newman, Robert Howard

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.